Viatris Inc (VTRS) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Viatris Inc   (NASDAQ: VTRS)
 

Viatris Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Viatris Inc inventory turnover ratio, the Viatris Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.43 in the third quarter 2026, VTRS's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Viatris Inc in Sep 30 2026 quarter, has decreased to 150 days, compare to 151 days, in the Jun 30 2026 quarter.

Within Healthcare sector 164 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1469, from total ranking in the second quarter 2026 at 1684.

VTRS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Viatris Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VTRS Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -6.86 % -7.76 % -4.14 % 3.76 % 0.66 %
Y / Y Cost of Sales Growth -3.22 % 2.27 % 12.74 % 10.49 % 4.21 %
Inventory Turnover Ratio (TTM) 2.43 2.41 2.34 2.26 2.22
VTRS's Total Ranking # 1469 # 1684 # 1535 # 1545 # 1526
Average inventory processing period 150 152 156 162 165
Seq. Inventory Growth -2.64 % 0.16 % -1.81 % -2.73 % -3.59 %
Seq. Cost of Sales Growth 0.49 % -2.52 % -7.67 % 7 % 6.19 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 45
Healthcare Sector # 165
Overall Market # 1469

Inventory Turnover Ratio Statistics
High Average Low
2.82 2.41 0.74
(Dec 31 2021)   (Mar 31 2021)



VTRS Company Profile >> Back to VTRS Efficiency Comparisons >> Compare VTRS Inventory Turnover Ratio to its Competitors

Financial Statements
Viatris Inc 's Inventories $ 3,829 Millions Visit VTRS's Balance sheet
Viatris Inc 's Cost of Revenues TTM $ 9,527 Millions Visit VTRS's Income Statement
What are VTRS's Sales? Visit VTRS's Sales by Segment

Other Inventory Turnover Ratios
Viatris Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VTRS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VTRS's Competitors
Inventory Turnover Ratio for VTRS's Suppliers
Inventory Turnover Ratio for VTRS's Customers

You may also want to know
VTRS's Sales Growth Rates VTRS's Pe Price to earnings ratio VTRS's Receivables Turnover Ratio VTRS's Stock Quote
VTRS's Net Income Growth Rates VTRS's Ps Price to Sales ratio VTRS's Sales per Employee VTRS's Asset Turnover Ratio
VTRS's Net Margin VTRS's Pb Price to Book ratio VTRS's Financial Strength Ratios VTRS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,910.255  Millions$ 658  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions

Date modified: 2026-11-06T13:03:53+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.